SCR-LIP-000544 · Claim · machine-readable JSON →
In 188 lower limbs of 94 women, standard lymphoscintigraphy criteria overdiagnosed lymphedema in lipedema patients with only 38.3% specificity, but modified interpretation (excluding delayed transit and reduced injection-site uptake) raised specificity to 80.85% at the cost of reduced sensitivity.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Enhancing lymphoscintigraphic specificity of lymphoedema diagnosis in patients with lipoedema (2025) ✓ verified — refining · cross sectional · 2025 · reading confidence: high
“Using lymphoscintigraphy to diagnose lymphoedema in patients with lipoedema resulted in low specificity (38.3%). By adjusting the interpretation criteria of the lymphoscintigraphic anomalies, we could achieve a specificity of 80.85%”
The article shows standard lymphoscintigraphy has poor specificity (38.3%) and overdiagnoses lymphedema in lipedema patients, meaning it does not reliably differentiate the two unless interpretation criteria are modified, which still trades
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000030
- 2026-11-20 — consolidated · SQ-LIP-000030: evidence moved to SCR-LIP-000741